Kenkhuis 2018.
| Study characteristics | |||
| Patient Sampling | Study design: prospective observational study Recruitment: all pregnant women who chose to have a combined test during the study period were asked to participate in the study Study start and end date: November 2012 to December 2015 |
||
| Patient characteristics and setting | Setting: multicentre (8) (6 ultrasound practices ‐ primary care facilities; Isala Hospital ‐ secondary care facility; University Medical Center Groningen ‐ tertiary care facility) Region(s) and country/countries from which participants were recruited: Groningen and Overrijsel, the Netherlands Sample size: 5021 Study eligibility criteria: high‐ and low‐risk pregnant women opting for the combined test Number of participants with the target condition: 68 Population type: pregnant women opting for the combined test Prior testing: combined test at the time of the first‐trimester scan |
||
| Index tests |
Type: two‐stage screening First‐trimester scan: Timing (weeks and days gestation): 11 weeks and 0 days to 13 weeks and 6 days of gestation Ultrasound scanning protocol: detailed Cardiac screening: extended Mode of examination: primary transabdominal, transvaginal if necessary Single or multiple operators: multiple Staff qualification and/or operator experience level: sonographers, certified for the performance of nuchal translucency measurement Second‐trimester scan: Timing: in the 20th week of gestation Ultrasound scanning protocol: not reported Cardiac screening: not reported Mode of examination: not reported Single or multiple operators: not reported Staff qualification and/or operator experience level: not reported |
||
| Target condition and reference standard(s) | Target condition(s): fetal structural anomalies (any type) Definitions used for major and minor congenital abnormalities: not reported Reference standard (live birth): pregnancy and neonatal outcomes from hospital records, follow‐up forms provided to participating practices and hospitals Reference standard (fetal or neonatal demise): if available, pathology records Postnatal follow‐up duration: not reported |
||
| Flow and timing | Eligible patients: 5534 Exclusions (study investigator): 495 lost to follow‐up (8.9%) Exclusions (review team): 18 (1 soft marker for chromosomal abnormalities, 17 non‐structural anomalies) |
||
| Comparative | |||
| Notes | Funding source: not reported | ||
| Methodological quality | |||
| Item | Authors' judgement | Risk of bias | Applicability concerns |
| DOMAIN 1: Patient Selection | |||
| Was a consecutive or random sample of patients enrolled? | Yes | ||
| Was a case‐control design avoided? | Yes | ||
| Did the study avoid inappropriate exclusions? | Yes | ||
| Could the selection of patients have introduced bias? | Low risk | ||
| Are there concerns that the included patients and setting do not match the review question? | Unclear | ||
| DOMAIN 2: Index Test (First‐trimester scan) | |||
| Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
| If a threshold was used, was it pre‐specified? | Yes | ||
| Could the conduct or interpretation of the index test have introduced bias? | Low risk | ||
| Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
| DOMAIN 2: Index Test (First + second‐trimester scan) | |||
| Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
| If a threshold was used, was it pre‐specified? | Yes | ||
| Could the conduct or interpretation of the index test have introduced bias? | Low risk | ||
| Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
| DOMAIN 2: Index Test (Single second‐trimester scan) | |||
| DOMAIN 3: Reference Standard | |||
| Is the reference standard likely to correctly classify anomalies that are externally visible, present with clinically relevant symptoms shortly after birth, or that are considered to be lethal/incompatible with life? | Yes | ||
| Is the reference standard likely to correctly classify anomalies that may present after discharge from postnatal care? | Unclear | ||
| Were the reference standard results interpreted without knowledge of the results of the index test? | No | ||
| Could the reference standard, its conduct, or its interpretation have introduced bias? | Unclear risk | ||
| Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
| DOMAIN 4: Flow and Timing | |||
| Did all live‐born infants receive a reference standard? | Yes | ||
| Did all live‐born infants receive the same reference standard? | No | ||
| Did all cases of fetal or perinatal loss receive the reference standard (including termination of pregnancy, intra‐uterine death, stillbirth, perinatal mortality)? | Unclear | ||
| Were all patients included in the analysis? | No | ||
| Could the patient flow have introduced bias? | Unclear risk | ||